id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-N-1148-0011,FDA,FDA-2012-N-1148,Food and Drug Administration Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products; Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing; Extension of Comment Period,Proposed Rule,Extension of Comment Period,2013-01-03T05:00:00Z,2013,1,2013-01-03T05:00:00Z,2013-01-17T04:59:59Z,2014-05-28T01:07:54Z,2012-31578,0,0,09000064811a3b89
FDA-2012-N-1148-0004,FDA,FDA-2012-N-1148,Testimony Regarding NRT and Innovative Tobacco Cessation - Testimony,Supporting & Related Material,Testimony,2012-12-20T05:00:00Z,2012,12,,,2012-12-20T20:24:03Z,,0,0,090000648119460a
FDA-2012-N-1148-0005,FDA,FDA-2012-N-1148,Slides Presented at 12/17/12 Public Hearing,Supporting & Related Material,Background Material,2012-12-20T05:00:00Z,2012,12,,,2013-01-10T21:35:52Z,,0,0,0900006481194525
FDA-2012-N-1148-0001,FDA,FDA-2012-N-1148,Actions Related to Nicotine Replacement Therapies and Smoking-Cessation Products: Report to Congress on Innovative Products and Treatments for Tobacco Dependence; Public Hearing,Proposed Rule,Public Hearing,2012-11-28T05:00:00Z,2012,11,2012-11-28T05:00:00Z,2013-01-03T04:59:59Z,2013-09-09T01:02:00Z,2012-28835,0,0,09000064811762a5